drugset / Trial / NCT02953132

A Clinical Study to See How the Study Drug MT-4129 is Taken up by the Body in Healthy Volunteers

NCT02953132

Phase 1 Completed 116 enrolled Tanabe Pharma Corporation
RandomizedParallel-groupDouble-blindOther

Summary

The purpose of this study is to investigate the safety and tolerability of ascending single and multiple oral doses of MT-4129 in healthy subjects.

Timeline

Start
2016-11
Primary completion
2017-05
Completion
2017-05

Drugs

EvaluationDrugModalityDoseRoute
Subject lorundrostat Small molecule Oral

Indications

No indication recorded.